Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore

10.1080/14737167.2023.2295474

Saved in:
Bibliographic Details
Main Authors: Elaine Hsuen Lim, Andrew Lim, Jasmeet Singh Khara, John Cheong, Jek Fong, Sivabalan Sivanesan, Matt Griffiths, Emma New, Soo-chin Lee
Other Authors: MEDICINE
Format: Article
Published: Taylor & Francis 2024
Online Access:https://scholarbank.nus.edu.sg/handle/10635/247511
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-247511
record_format dspace
spelling sg-nus-scholar.10635-2475112024-03-18T03:10:59Z Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore Elaine Hsuen Lim Andrew Lim Jasmeet Singh Khara John Cheong Jek Fong Sivabalan Sivanesan Matt Griffiths Emma New Soo-chin Lee MEDICINE 10.1080/14737167.2023.2295474 Expert Review of Pharmacoeconomics & Outcomes Research 24 3 413-426 2024-03-18T03:10:56Z 2024-03-18T03:10:56Z 2024-01-30 Article Elaine Hsuen Lim, Andrew Lim, Jasmeet Singh Khara, John Cheong, Jek Fong, Sivabalan Sivanesan, Matt Griffiths, Emma New, Soo-chin Lee (2024-01-30). Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore. Expert Review of Pharmacoeconomics & Outcomes Research 24 (3) : 413-426. ScholarBank@NUS Repository. https://doi.org/10.1080/14737167.2023.2295474 1473-7167 https://scholarbank.nus.edu.sg/handle/10635/247511 Taylor & Francis Taylor & Francis
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
description 10.1080/14737167.2023.2295474
author2 MEDICINE
author_facet MEDICINE
Elaine Hsuen Lim
Andrew Lim
Jasmeet Singh Khara
John Cheong
Jek Fong
Sivabalan Sivanesan
Matt Griffiths
Emma New
Soo-chin Lee
format Article
author Elaine Hsuen Lim
Andrew Lim
Jasmeet Singh Khara
John Cheong
Jek Fong
Sivabalan Sivanesan
Matt Griffiths
Emma New
Soo-chin Lee
spellingShingle Elaine Hsuen Lim
Andrew Lim
Jasmeet Singh Khara
John Cheong
Jek Fong
Sivabalan Sivanesan
Matt Griffiths
Emma New
Soo-chin Lee
Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore
author_sort Elaine Hsuen Lim
title Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore
title_short Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore
title_full Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore
title_fullStr Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore
title_full_unstemmed Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore
title_sort cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in singapore
publisher Taylor & Francis
publishDate 2024
url https://scholarbank.nus.edu.sg/handle/10635/247511
_version_ 1794549269168914432